InnoTherapy Obtains Indian International Patent for Hemostatic Agent
[Asia Economy Reporter Geum Bo-ryeong] InnoTherapy announced on the 4th that it has obtained an Indian international patent related to 'hydrogel containing chitosan or polyamine conjugated with catechol groups and poloxamer conjugated with thiol groups at the terminals, its manufacturing method, and a hemostatic agent using the same.'
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- "Why This Bonus Grade?" Civil Servant Who Assaulted HR Employee... Court Rules Demotion Is Justified
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
InnoTherapy stated, "This invention is a patent concerning an adhesive hydrogel composition including chitosan conjugated with catechol groups and Pluronic conjugated with thiol groups at the terminals," adding, "It is stable both in vivo and in vitro, has excellent hemostatic effects, and can be applied as a hemostatic agent and bioadhesive."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
